092730 — NeoPharm Co Balance Sheet

0.000.00%

Last trade - 00:00

Consumer DefensivesAdventurousSmall CapSuper Stock

Market Cap
KR₩202bn
Enterprise Value
KR₩91bn
Revenue
KR₩97bn

Annual balance sheet for NeoPharm Co, fiscal year end - December 31st, KRW millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	Annual Audited Accounts	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	85,515	96,181	105,049	113,485	111,990
Net Total Accounts Receivable
Net Total Receivables	9,626	8,863	8,045	7,665	10,383
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	101,680	113,551	121,484	131,270	134,502
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	10,496	10,121	9,743	9,341	29,244
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	122,742	132,978	143,408	155,347	177,459
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	12,831	14,877	12,941	13,137	16,945
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Minority Interest
Total Other Liabilities
Total Funded Status
Total Liabilities	17,049	15,260	13,103	13,137	17,433
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Treasury Stock
ESOP Debt Guarantee
Unrealized Gain / Loss
Other Equity
Total Equity	105,693	117,718	130,305	142,211	160,026
Total Liabilities & Shareholders' Equity	122,742	132,978	143,408	155,347	177,459
Total Common Shares Outstanding